ANTIBODY-DRUG COMPLEX
An antibody-drug complex represented by formula (I): (in the formula, Ab is an antibody, X is a group represented by formula (X-1), formula (X-2), or formula (X-3): (in the formulas, AA on the left represents a binding site with NH, BB on the right represents a binding site with D.), D is a group represented by formula (D-1) or formula (D-2): (in the formulas, CC represents a binding site with X.), and n ranges from about 1 to about 8.)..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Europäisches Patentamt - (2024) vom: 29. Feb. Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
MIYANO MASAYUKI [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-02-29, Last update posted on www.tib.eu: 2024-04-03, Last updated: 2024-04-09 |
---|
Patentnummer: |
WO2024043319 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA00128035X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA00128035X | ||
003 | DE-627 | ||
005 | 20240409142932.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240322s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA00128035X | ||
035 | |a (EPA)WO2024043319 | ||
035 | |a (EPA)90013499 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a MIYANO MASAYUKI |e verfasserin |4 aut | |
245 | 1 | 0 | |a ANTIBODY-DRUG COMPLEX |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2024-02-29, Last update posted on www.tib.eu: 2024-04-03, Last updated: 2024-04-09 | ||
520 | |a An antibody-drug complex represented by formula (I): (in the formula, Ab is an antibody, X is a group represented by formula (X-1), formula (X-2), or formula (X-3): (in the formulas, AA on the left represents a binding site with NH, BB on the right represents a binding site with D.), D is a group represented by formula (D-1) or formula (D-2): (in the formulas, CC represents a binding site with X.), and n ranges from about 1 to about 8.). | ||
650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a NAKAZAWA YUYA |e verfasserin |4 aut | |
700 | 0 | |a ISO KENTARO |e verfasserin |4 aut | |
700 | 0 | |a YABE YUKI |e verfasserin |4 aut | |
700 | 0 | |a UMIHARA HIROTATSU |e verfasserin |4 aut | |
700 | 0 | |a TAGUCHI JUNICHI |e verfasserin |4 aut | |
700 | 0 | |a INOUE SATOSHI |e verfasserin |4 aut | |
700 | 0 | |a TSUKAMOTO SHUNTARO |e verfasserin |4 aut | |
700 | 0 | |a KOGAI HIROYUKI |e verfasserin |4 aut | |
700 | 0 | |a YAMAGUCHI ATSUMI |e verfasserin |4 aut | |
700 | 0 | |a AKAGI TSUYOSHI |e verfasserin |4 aut | |
700 | 0 | |a MUKAI YOHEI |e verfasserin |4 aut | |
700 | 0 | |a HIRAYAMA TOSHIFUMI |e verfasserin |4 aut | |
700 | 0 | |a KATO MASAKI |e verfasserin |4 aut | |
700 | 0 | |a MOCHIZUKI TOSHIKI |e verfasserin |4 aut | |
700 | 0 | |a YAMAMOTO AKIHIKO |e verfasserin |4 aut | |
700 | 0 | |a YAMAMOTO YUJI |e verfasserin |4 aut | |
700 | 0 | |a SAKURADA TAKATO |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 29. Feb. |
773 | 1 | 8 | |g year:2024 |g day:29 |g month:02 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/90013499/publication/WO2024043319A1?q=WO2024043319 |m X:VERLAG |x 0 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2024 |b 29 |c 02 |